Point72 Middle East FZE’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-7,243	Closed	-$258K	–	1324
2023 Q3	$258K	Sell	7,243 -15,461	-68%	-$551K	0.01%	522
2023 Q2	$1.05M	Buy	22,704 +20,437	+901%	+$943K	0.03%	301
2023 Q1	$90.9K	Buy	2,267 +1,789	+374%	+$71.7K	﹤0.01%	631
2022 Q4	$22.1K	Buy	+478	New	+$22.1K	﹤0.01%	1072